Skip to main content
. 2016 Nov 30;13(1):194–202. doi: 10.3892/etm.2016.3935

Table VII.

Blood examination results at week 20.

Treatment (n=17) Placebo (n=15) P-value
ALT, IU/la 23.65±8.48 21.00±9.36 0.408
AST, IU/la 20.00±4.03 19.20±4.00 0.578
r-GT, U/la 40.35±42.09 21.67±16.53 0.106
BUN, mg/dlb 12.90 (3.59) 12.50 (4.01) 0.866
Creatinine, mg/dla 0.75±0.14 0.75±0.16 0.994
Iron, mg/dla 103.24±38.52 107.00±41.01 0.791
Ferritin, ng/mla 166.98±106.01 183.61±105.83 0.661
WBC, 103/mm3 b 5.92 (2.35) 5.42 (1.59) 0.202
RBC, million/mm3 b 5.06 (0.49) 4.85 (0.70) 0.538
Hb, g/dlb 15.20 (1.40) 14.80 (1.90) 0.549
Hct, %b 43.50 (3.10) 42.70 (5.70) 0.955
DHEA, ng/mlb 207.30 (105.30) 236.10 (161.00) 0.575
Testosterone, ng/mla 14.77±48.02 3.11±2.07 0.332
Estradiol, ng/mla 37.65±10.40 56.33±33.13 0.052
a

Mean ± standard deviation

b

median (interquartile range). ALT, alanine aminotranferease; AST, aspartate aminotransferase; r-GT, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; DHEA, dehydroepiandrosterone.